🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether the rituximab administrat...
Status
Completed
Location
Hospital Infanta Cristina
Start Date
2004-09
Trial ID
NCT01124526
Treatments Being Tested
BBR 2778 is a novel aza-anthracenedione that has activity in experimental t...
Status
Withdrawn
Location
Northwest Alabama Cancer Center
Start Date
2007-09
Trial ID
NCT00577161
Treatments Being Tested
This phase I trial studies the side effects and best dose of genetically mo...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2015-05-18
Trial ID
NCT02208362
Treatments Being Tested
Purpose of the study is the comparative evaluation of the clinical efficacy...
Status
Completed
Location
Private Consulting
Start Date
2003-03
Trial ID
NCT00335725
Treatments Being Tested
This phase II trial studies how well a dose adjusted regimen consisting of ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-01-14
Trial ID
NCT02199184
The primary purpose of the investigation is to identify differences in embr...
Status
Terminated
Location
The fertility clinic
Start Date
2011-04
Trial ID
NCT01345812
Treatments Being Tested
The COR-INSIGHT trial aims to evaluate the effectiveness of Peerbridge COR ...
Status
Enrolling By Invitation
Location
Peerbridge Health, Melbourne, Florida 32935
Start Date
2024-11-16
Trial ID
NCT06763549
This phase IB trial studies the feasibility of using a functional laborator...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2016-01-13
Trial ID
NCT02779283
Treatments Being Tested
This research is being done to determine the efficacy of selpercatinib to r...
Status
Recruiting
Location
MedStar Washington Hospital Center
Start Date
2023-03-01
Trial ID
NCT05668962
Treatments Being Tested
This phase I/Ib trial studies the side effects and best dose of parsaclisib...
Status
Active Not Recruiting
Location
Mayo Clinic in Arizona
Start Date
2020-06-15
Trial ID
NCT04323956